BrightSpring Health Services Inc - Unit
BTSGU - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$45.16B
Close$
Earnings Call Q1 2026
May 1, 2026 - AI Summary
Strong Q1 results and momentum across segments (good / key takeaways):
- Total revenue: $3.6B, +26% YoY
- Pharmacy Solutions revenue: $3.2B, +25% YoY
- Provider Services revenue: $442M, +28% YoY
- Adjusted EBITDA: $190M, +45% YoY; margin ~5.3% (+70 bps YoY) driven by mix + operational efficiencies
- Cash flow from operations: $123M in the quarter (excluding cash flow impact from the Community Living divestiture)
- Quality/operational execution: high star ratings/timeliness in Home Health; hospice quality metrics above national average; pharmacy dispensing accuracy ~99.99% and on-time delivery ~96%; infusion discharge completion therapy ~97%
Balance sheet de-risking from Community Living sale; leverage improving (good / notable):
- Community Living sale completed March 30, 2026; proceeds ~$811M net cash before tax (gross consideration ~$835M)
- Leverage: 2.27x as of March 31, 2026 (down from 2.99x at Dec 31, 2025)
- Pro forma leverage: 2.40x after accounting for cash taxes to be paid in Q2
- Management stated they remain active in evaluating term loan/capital structure options given strong operating performance
2026 guidance updated/affirmed for “continuing operations,” with range-based forecasts (good / critical for investors):
- Guidance excludes Community Living and any not-yet-closed acquisitions
- Total revenue: $14.725B–$15.225B (implies ~14.1% to 17.9% growth vs 2025, excluding Community Living in both years)
- Pharmacy Solutions revenue: $12.85B–$13.3B
- Provider Services revenue: $1.875B–$1.925B
- Adjusted EBITDA: $795M–$825M (implies ~28.7% to 33.6% growth vs 2025, excluding Community Living)
- Amedisys/LHC acquisition contribution: ~$30M of EBITDA in year 1
- Management said they are on track to deliver the updated full-year guidance provided today
Exclusive for Stockcircle Pro members
Sign up
$2.02
99.1% downside
Current Fair Value
99.1% downsideOvervalued by 99.1% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $45.16 Billion |
|---|---|
| Enterprise Value | $44.85 Billion |
| Annual dividend | $3.38 |
| Earnings per Share | $0.94 |
| Beta | 1.81 |
| Outstanding Shares | 207,022,000 |
Return
| Return on Equity | 20.03% |
|---|---|
| Return on Assets | 6.85% |
| Return on Invested Capital | 11.70% |
Valuation & Multiples
| P/E Ratio | 40.79 |
|---|---|
| PEG | 51.41 |
| Price to Sales | 2.99 |
| Price to Book Ratio | 24.24 |
| Enterprise Value to Revenue | 2.94 |
| Enterprise Value to EBIT | 86.57 |
| Enterprise Value to Net Income | 109 |
| Total Debt to Enterprise | 0.01 |
| Debt to Equity | 0.12 |
Revenue Sources
No data
Last Earnings Call
Report Date
October 30, 2026
EPS Estimate
$0.47
Consensus analyst estimateRevenue Estimate
$3.88 B
Consensus analyst estimateNext Earnings Call
Expected Date
February 26, 2027
EPS Estimate
$0.52
Consensus analyst estimateRevenue Estimate
$4.12 B
Consensus analyst estimateInstitutional Put/Call Ratio
Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 1.39%▼ 0.44% |
|---|---|
| Total Invested | $647.48M▲ 21.69% |
| Investors Holding | 32▲ 1.00% |